跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PMS-ZOLPIDEM ODT - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PMS-ZOLPIDEM ODT
Authorized
STANDARD
PMS-ZOLPIDEM ODT
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
68852e6803e5cb2c
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
68852e6803e5cb2c
Drug Approval Canada Name
PMS-ZOLPIDEM ODT
Product Name
PMS-ZOLPIDEM ODT
Status
Marketed
Status Date
2016-12-13
Original Market Date
2016-12-13
Din
02436175
Drug Class
Human
Dosage Form
Tablet (Orally Disintegrating)
Route Of Administration
Sublingual
Schedule
Targeted (CDSA IV)
Ahfs
28:24.92
Atc Original
N05CF02 ZOLPIDEM
Atc Name
n 05 cf 02
Aig Number
0122857001
Company Name
Pharmascience Inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
ZOLPIDEM TARTRATE
5 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
68852e6803e5cb2c
Type
Standard
Back to Health Canada Approvals